Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2016.09.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation

Case Reports in Immunology
AllergyImmunology
2020English

Significance of M-Components in Plasma Cell Myeloma and Related Disorders

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1970English

CD5-positive Chronic B-Cell Lymphoproliferative Disorders: Diagnosis and Prognosis of a Heterogeneous Disease Entity

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2010English

Expression of CD81 and CD117 in Plasma Cell Myeloma and the Relationship to Prognosis

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Posttransplantation Lymphoproliferative Disorder Initially Seen as Iris Mass and Uveitis

Archives of Ophthalmology
2001English

Plasma Cell Satellitism in Plasma Cell Myeloma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Lymphoproliferative Disorders

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy